Prab: Created page with "{{Short description|Zepbound weight loss, tirzepatide injections, insurance prior authorization, and medical weight loss care at W8MD}} {{DISPLAYTITLE:Zepbound Weight Loss}} NOTOC {{Infobox drug | drug_name = Zepbound | image = 250px | caption = Weight loss results vary by patient and require medical supervision, nutrition planning, activity, and long-term maintenance. | tradename = Zepbound | generic_name = Tirzepati..."

2026-07-11T01:53:10Z

Created page with "{{Short description|Zepbound weight loss, tirzepatide injections, insurance prior authorization, and medical weight loss care at W8MD}} {{DISPLAYTITLE:Zepbound Weight Loss}} __NOTOC__ {{Infobox drug | drug_name = Zepbound | image = 250px | caption = Weight loss results vary by patient and require medical supervision, nutrition planning, activity, and long-term maintenance. | tradename = Zepbound | generic_name = Tirzepati..."

New page

{{Short description|Zepbound weight loss, tirzepatide injections, insurance prior authorization, and medical weight loss care at W8MD}}
{{DISPLAYTITLE:Zepbound Weight Loss}}
__NOTOC__

{{Infobox drug
| drug_name = Zepbound
| image = [[File:Before-and-after-weight-loss.jpeg|250px]]
| caption = Weight loss results vary by patient and require medical supervision, nutrition planning, activity, and long-term maintenance.
| tradename = [[Zepbound]]
| generic_name = [[Tirzepatide]]
| drug_class = [[Dual GIP and GLP-1 receptor agonist]], [[anti-obesity medication]], [[incretin mimetic]]
| routes_of_administration = [[Subcutaneous injection]]
| frequency = Once weekly
| uses = [[Chronic weight management]], [[obesity]], [[overweight]] with weight-related conditions, [[obstructive sleep apnea]] in selected adults with obesity
| mechanism = Appetite reduction, improved satiety, delayed gastric emptying, glucose-dependent insulin secretion, reduced glucagon secretion
| related = [[Mounjaro]], [[Wegovy]], [[Ozempic]], [[Semaglutide]], [[GLP-1 weight loss injections]], [[GIP]]
}}

<div style="max-width:1120px; margin:0 auto; font-size:1.05em; line-height:1.65;">

<div style="background:linear-gradient(135deg,#f5f9ff,#eef7f0); border:1px solid #c9ddf2; border-radius:16px; padding:28px; margin:20px 0; box-shadow:0 3px 10px rgba(0,0,0,0.08);">

[[File:Weight-loss-150.png|right|170px|link=Medical weight loss|alt=W8MD physician supervised Zepbound weight loss program]]

<h1 style="margin-top:0; color:#1f4e79;">Zepbound Weight Loss</h1>

<p style="font-size:1.18em;">'''Zepbound weight loss''' refers to medically supervised weight reduction using '''[[Zepbound]]''', the brand name for '''[[tirzepatide]]''', a once-weekly injectable prescription medication used for [[chronic weight management]] in adults with [[obesity]] or [[overweight]] with weight-related medical conditions. Zepbound is part of the newer generation of [[GLP-1 weight loss injections]] and [[dual GIP and GLP-1 receptor agonist]] medications.</p>

<p>At '''[[W8MD Weight Loss, Sleep and MedSpa]]''', eligible patients in the '''Greater New York City area, [[New Jersey]], [[Connecticut]], [[Pennsylvania]], [[Delaware]], Brooklyn, Philadelphia, and surrounding regions''' can be evaluated for Zepbound, brand-name GLP-1/GIP therapy, or tirzepatide-based options depending on medical appropriateness, patient preference, medication availability, and insurance coverage.</p>

<div style="display:flex; flex-wrap:wrap; gap:14px; margin:22px 0;">

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">Zepbound</div>
<div>Brand-name [[tirzepatide]] for chronic weight management</div>
</div>

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">Tirzepatide</div>
<div>Dual [[GIP]] and [[GLP-1 receptor agonist]] therapy</div>
</div>

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">Prior authorization</div>
<div>W8MD physicians can help when insurance coverage is available and criteria are met</div>
</div>

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">NY, NJ, CT, PA, DE</div>
<div>Serving patients across the greater Northeast region</div>
</div>

</div>

<div style="background:#fff8df; border:2px solid #f2c94c; border-radius:12px; padding:16px; margin:20px 0;">
'''W8MD program highlight:''' When a patient qualifies and insurance coverage is available, W8MD physicians can evaluate the patient, document medical necessity, and help obtain '''prior authorization for Zepbound''' when appropriate. For patients who prefer a non-brand tirzepatide option or whose insurance does not cover Zepbound, W8MD can discuss medically appropriate tirzepatide-based alternatives, when available and legally appropriate.
</div>

<div style="text-align:center; margin:24px 0;">
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-45198 Book Brooklyn Appointment]</span>
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-48161 Book Philadelphia Appointment]</span>
</div>

</div>

[[File:W8MD-Team.jpg|thumb|right|350px|[[W8MD Weight Loss, Sleep and MedSpa]] provides physician-supervised weight loss, GLP-1 medication evaluation, nutrition support, and sleep apnea care.]]
[[File:Woman-losing-weight.jpeg|thumb|right|350px|Zepbound and tirzepatide-based weight loss programs work best when paired with nutrition, protein planning, physical activity, sleep optimization, and medical follow-up.]]
[[File:Body mass index chart.svg|thumb|right|300px|[[Body mass index]] is one tool used to determine eligibility for anti-obesity medications such as Zepbound.]]
[[File:Obesity-waist circumference.svg|thumb|right|300px|[[Waist circumference]] and [[visceral fat]] are important markers of metabolic risk.]]

==Overview==

'''Zepbound''' is an FDA-approved prescription medication containing [[tirzepatide]]. It is used with a [[reduced-calorie diet]] and increased [[physical activity]] for long-term weight management in adults with [[obesity]] or adults with [[overweight]] who have at least one weight-related condition such as [[high blood pressure]], [[type 2 diabetes]], or [[high cholesterol]].<ref name="FDAZepboundWeight">{{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management|title=FDA Approves New Medication for Chronic Weight Management|publisher=U.S. Food and Drug Administration|date=2023-11-08|accessdate=2026-07-10}}</ref>

Zepbound is also FDA-approved for [[moderate-to-severe obstructive sleep apnea]] in adults with [[obesity]], to be used with a reduced-calorie diet and increased physical activity.<ref name="FDAZepboundOSA">{{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea|title=FDA Approves First Medication for Obstructive Sleep Apnea|publisher=U.S. Food and Drug Administration|date=2024-12-20|accessdate=2026-07-10}}</ref>

For W8MD patients, Zepbound may be considered as part of a comprehensive [[obesity medicine]] program that can include [[medical weight loss]], [[nutrition counseling]], [[meal planning]], [[protein shake]] support, [[resistance training]], [[sleep apnea screening]], [[home sleep study]], [[CPAP]], [[APAP]], [[BiPAP]], and long-term [[weight maintenance]].

==What is Zepbound?==

'''Zepbound''' is the weight-loss brand name for [[tirzepatide]]. Tirzepatide is a '''[[dual GIP and GLP-1 receptor agonist]]''', meaning it activates two hormone pathways involved in appetite, fullness, and glucose regulation:

* [[GIP]] - [[glucose-dependent insulinotropic polypeptide]]
* [[GLP-1]] - [[glucagon-like peptide-1]]

These incretin hormones affect:

{{div col|colwidth=18em}}
* [[Appetite regulation]]
* [[Satiety]]
* [[Food noise]]
* [[Gastric emptying]]
* [[Insulin secretion]]
* [[Glucagon suppression]]
* [[Blood glucose]]
* [[Energy balance]]
* [[Body weight]]
{{div col end}}

==Zepbound versus generic tirzepatide options==

Many patients search for “generic Zepbound,” “generic tirzepatide,” or “tirzepatide weight loss shots.” It is important to understand the difference between the brand name and the active ingredient.

{| class="wikitable" style="width:100%;"
! Term
! Meaning
! W8MD patient education point
|-
| '''Zepbound'''
| Brand-name tirzepatide product approved for chronic weight management and selected sleep apnea use
| Best option when covered by insurance or preferred by the patient and medically appropriate
|-
| '''Tirzepatide'''
| Active ingredient in Zepbound and Mounjaro
| May be discussed as the medication molecule or as a tirzepatide-based treatment option when appropriate
|-
| '''Mounjaro'''
| Brand-name tirzepatide product used for [[type 2 diabetes]]
| Patients often search for [[Mounjaro for weight loss]], but Zepbound is the weight-loss brand
|-
| '''Non-brand tirzepatide options'''
| Tirzepatide-based options that may vary by pharmacy, availability, regulation, and clinical appropriateness
| W8MD can discuss patient preference, cost, availability, and safety; patients should avoid unsafe online products or research peptides
|}

W8MD physicians can help patients compare brand-name Zepbound, insurance-covered GLP-1/GIP therapy, and tirzepatide-based options based on medical history, side effects, cost, availability, and insurance rules.

==Who may qualify for Zepbound?==

A patient may qualify for Zepbound if they meet clinical criteria such as:

{{div col|colwidth=20em}}
* [[BMI]] of 30 kg/m<sup>2</sup> or higher
* BMI of 27 kg/m<sup>2</sup> or higher with a weight-related condition
* [[High blood pressure]]
* [[High cholesterol]]
* [[Type 2 diabetes]]
* [[Prediabetes]]
* [[Sleep apnea]]
* [[Metabolic syndrome]]
* [[Osteoarthritis]]
* [[Gastroesophageal reflux disease]]
* [[Metabolic dysfunction-associated steatotic liver disease]]
* [[Cardiovascular disease]]
{{div col end}}

Final eligibility depends on medical evaluation, contraindications, insurance criteria, medication availability, and prescriber judgment.

==Insurance coverage and prior authorization==

Insurance coverage for Zepbound varies widely. Some patients may have coverage through commercial insurance, employer plans, or pharmacy benefits, while others may face exclusions for weight-loss medications.

When insurance coverage is available and the patient qualifies, '''W8MD physicians can help obtain prior authorization for Zepbound''' by documenting medical necessity and submitting relevant clinical information.

Prior authorization may require:

{{div col|colwidth=20em}}
* Current [[BMI]]
* [[Weight history]]
* Prior weight-loss attempts
* Diagnosis of [[obesity]] or [[overweight]]
* Weight-related conditions such as [[hypertension]], [[dyslipidemia]], [[type 2 diabetes]], or [[sleep apnea]]
* Current medication list
* Documentation of lifestyle intervention
* Medical visit notes
* Lab results when appropriate
* Insurance-specific forms
{{div col end}}

Approval is not guaranteed. Insurance decisions depend on the patient’s plan, benefit exclusions, diagnosis, documentation, step therapy requirements, pharmacy benefit rules, and payer policies.

==How W8MD can help==

<div style="background:#f8fbff; border:1px solid #d6e6f5; border-radius:14px; padding:22px; margin:22px 0;">

<h2 style="margin-top:0; color:#1f4e79;">W8MD Zepbound and tirzepatide program highlights</h2>

<div style="display:flex; flex-wrap:wrap; gap:14px; margin:16px 0;">

<div style="flex:1; min-width:240px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Physician-supervised care'''<br />
W8MD provides [[obesity medicine]] visits, medication review, side-effect monitoring, and long-term follow-up.
</div>

<div style="flex:1; min-width:240px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Brand or tirzepatide-based options'''<br />
Patients may discuss brand-name [[Zepbound]] or tirzepatide-based options depending on preference, availability, safety, and insurance coverage.
</div>

<div style="flex:1; min-width:240px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Prior authorization support'''<br />
When coverage is available and the patient qualifies, W8MD physicians can help submit prior authorization for Zepbound.
</div>

<div style="flex:1; min-width:240px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Sleep medicine integration'''<br />
W8MD can evaluate [[sleep apnea]], which is common in patients with obesity and may affect fatigue, cravings, and metabolic health.
</div>

</div>

</div>

W8MD can help with:

{{div col|colwidth=20em}}
* [[Zepbound for weight loss]]
* [[Tirzepatide weight loss]]
* [[Tirzepatide injection]]
* [[Mounjaro for weight loss]] education
* [[GLP-1 weight loss injections]]
* Insurance visit documentation
* Prior authorization when appropriate
* Self-pay medication discussions when available
* Nutrition and protein planning
* [[Meal replacements]]
* [[Low-carbohydrate diet]] counseling
* [[Exercise counseling]]
* [[Resistance training]] guidance
* [[Sleep apnea screening]]
* [[Home sleep study]]
* Long-term [[weight maintenance]]
{{div col end}}

==Expected Zepbound weight loss results==

<div style="background:#eef7f0; border:1px solid #b8dfc1; border-radius:14px; padding:22px; margin:22px 0;">

<h2 style="margin-top:0; color:#1f4e79;">Results patients care about</h2>

<div style="display:flex; flex-wrap:wrap; gap:14px;">

<div style="flex:1; min-width:230px; background:#ffffff; border-radius:10px; padding:16px; text-align:center;">
<div style="font-size:2em; font-weight:bold; color:#237a3b;">Weight loss</div>
<div>Clinically meaningful weight loss may improve mobility, energy, and quality of life.</div>
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-radius:10px; padding:16px; text-align:center;">
<div style="font-size:2em; font-weight:bold; color:#237a3b;">Metabolic health</div>
<div>Weight reduction may improve [[blood pressure]], [[blood glucose]], [[triglycerides]], and [[lipid profile]].</div>
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-radius:10px; padding:16px; text-align:center;">
<div style="font-size:2em; font-weight:bold; color:#237a3b;">Sleep apnea</div>
<div>For selected adults with obesity, Zepbound is also approved for moderate-to-severe [[obstructive sleep apnea]].</div>
</div>

</div>

</div>

In FDA-reviewed studies, patients receiving Zepbound had greater average weight reduction than placebo when used with lifestyle changes.<ref name="FDAZepboundWeight" /> Individual results vary based on dose, adherence, starting weight, medical history, nutrition, activity, sleep, medication access, and long-term follow-up.

==How Zepbound works for appetite and food noise==

Zepbound may help patients by reducing hunger and improving fullness. Many patients describe improvement in [[food noise]], meaning fewer constant thoughts about food, cravings, snacking, or difficulty stopping after meals.

Potential effects include:

{{div col|colwidth=18em}}
* Reduced [[appetite]]
* Increased [[satiety]]
* Smaller portions
* Reduced cravings
* Slower [[gastric emptying]]
* Improved [[blood glucose]] regulation
* Better ability to follow a nutrition plan
* Improved adherence to [[chronic weight management]]
{{div col end}}

==Zepbound dosing and dose escalation==

Zepbound is usually started at a low dose and increased gradually to improve tolerability.

{| class="wikitable" style="width:100%;"
! Dose
! Typical role
! Patient education point
|-
| 2.5 mg once weekly
| Starting dose
| Used to begin therapy and help the body adjust
|-
| 5 mg once weekly
| Maintenance option
| First commonly used maintenance dose
|-
| 7.5 mg once weekly
| Escalation step
| May be used before increasing further
|-
| 10 mg once weekly
| Maintenance option
| Common long-term dose for selected patients
|-
| 12.5 mg once weekly
| Escalation step
| May be used before 15 mg
|-
| 15 mg once weekly
| Maximum dose
| Highest approved weekly dose
|}

Patients should not change doses, skip dose-escalation steps, combine GLP-1 medications, or restart after a long interruption without medical guidance.

==Common side effects==

Common [[Zepbound side effects]] include:

{{div col|colwidth=18em}}
* [[Nausea]]
* [[Diarrhea]]
* [[Vomiting]]
* [[Constipation]]
* Abdominal discomfort
* [[Gastroesophageal reflux disease]]
* Burping
* Bloating
* Injection-site reactions
* [[Fatigue]]
{{div col end}}

Side effects often occur during dose escalation and may improve with smaller meals, slower eating, hydration, lower-fat food choices, and dose adjustment under medical supervision.

==Important warnings and precautions==

Zepbound is not appropriate for everyone. Patients should discuss risks and benefits with a healthcare provider, especially if they have:

{{div col|colwidth=20em}}
* Personal or family history of [[medullary thyroid carcinoma]]
* [[Multiple Endocrine Neoplasia syndrome type 2]]
* History of [[pancreatitis]]
* [[Gallbladder disease]]
* Severe gastrointestinal disease
* [[Kidney disease]]
* [[Type 1 diabetes]]
* Use of [[insulin]] or [[sulfonylurea]]
* [[Pregnancy]] or plans for pregnancy
* Breastfeeding
* Eating disorder history
* Severe dehydration risk
{{div col end}}

The official Zepbound prescribing information includes a boxed warning related to thyroid C-cell tumors observed in animal studies and contraindications for patients with personal or family history of medullary thyroid carcinoma or MEN2.<ref name="ZepboundLabel">{{cite web|url=https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s002lbl.pdf|title=Zepbound prescribing information|publisher=U.S. Food and Drug Administration|date=2026|accessdate=2026-07-10}}</ref>

==Zepbound and sleep apnea==

[[File:Sleep-150.png|right|150px|link=Sleep apnea|alt=W8MD sleep medicine services]]

Zepbound is especially relevant to W8MD because W8MD combines [[medical weight loss]] and [[sleep medicine]]. Many patients with obesity also have undiagnosed [[obstructive sleep apnea]], which can worsen:

{{div col|colwidth=18em}}
* Daytime fatigue
* Morning headaches
* Cravings
* [[High blood pressure]]
* [[Insulin resistance]]
* Difficulty losing weight
* Cardiovascular risk
{{div col end}}

Patients with snoring, witnessed pauses in breathing, choking or gasping during sleep, daytime sleepiness, resistant hypertension, or obesity may benefit from [[sleep apnea screening]] or a [[home sleep study]].

==Nutrition while taking Zepbound==

Zepbound reduces appetite, but nutrition quality remains essential. Patients may eat less, so protein, hydration, and micronutrients become even more important.

W8MD may recommend:

{{div col|colwidth=18em}}
* Protein-first meals
* [[Lean protein]]
* [[Greek yogurt]]
* [[Eggs]]
* [[Fish]]
* [[Poultry]]
* [[Protein shake]]
* Non-starchy vegetables
* [[Low-glycemic diet]] choices
* Hydration
* Electrolytes when appropriate
* Avoiding large greasy meals
* Avoiding sugary drinks
{{div col end}}

==Preserving muscle during Zepbound weight loss==

A good Zepbound program should help reduce excess [[adipose tissue]] and [[visceral fat]] while protecting [[lean body mass]].

Muscle-preservation strategies include:

{{div col|colwidth=18em}}
* Adequate protein intake
* [[Resistance training]]
* [[Walking]]
* [[Exercise counseling]]
* Monitoring [[body composition]]
* Avoiding extreme calorie restriction
* Treating [[sleep deprivation]]
* Long-term maintenance planning
{{div col end}}

==Zepbound in New York City, New Jersey, Connecticut, Pennsylvania, and Delaware==

Patients searching for '''Zepbound in NYC''', '''Zepbound near me''', '''Zepbound New Jersey''', '''Zepbound Connecticut''', '''Zepbound Philadelphia''', '''Zepbound Pennsylvania''', or '''Zepbound Delaware''' often want a medical practice that can evaluate them safely and help with medication access.

W8MD serves patients in and around:

{{div col|colwidth=18em}}
* [[Brooklyn]]
* [[New York City]]
* [[Manhattan]]
* [[Queens]]
* [[Staten Island]]
* [[Long Island]]
* [[New Jersey]]
* [[Connecticut]]
* [[Philadelphia]]
* [[Pennsylvania]]
* [[Delaware]]
* [[Greater Philadelphia]]
{{div col end}}

Services and medication options may vary by location, state rules, insurance plan, pharmacy availability, and clinical evaluation.

==Why medical supervision matters==

Medical supervision is important because Zepbound and tirzepatide-based medications require proper patient selection, dosing, monitoring, and follow-up.

W8MD medical supervision can help with:

{{div col|colwidth=20em}}
* Determining if Zepbound is appropriate
* Reviewing contraindications
* Checking medication interactions
* Choosing brand or tirzepatide-based options
* Managing nausea, constipation, diarrhea, or reflux
* Adjusting dose escalation
* Monitoring weight loss pace
* Supporting hydration and protein intake
* Preventing excessive muscle loss
* Coordinating sleep apnea evaluation
* Planning long-term maintenance
{{div col end}}

==Avoid unsafe online tirzepatide products==

Patients should avoid unapproved online “research” peptides, counterfeit Zepbound, counterfeit tirzepatide, or products marketed without legitimate medical supervision. The FDA has warned about concerns with unapproved GLP-1 drugs used for weight loss, including fraudulent compounded semaglutide and tirzepatide products with false labeling.<ref name="FDAUnapprovedGLP1">{{cite web|url=https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss|title=FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss|publisher=U.S. Food and Drug Administration|date=2026-02-04|accessdate=2026-07-10}}</ref>

==Frequently asked questions==

===Is Zepbound the same as tirzepatide?===

Yes. [[Tirzepatide]] is the active ingredient. [[Zepbound]] is the brand name used for chronic weight management and selected obstructive sleep apnea treatment in adults with obesity.

===Is Zepbound the same as Mounjaro?===

Zepbound and [[Mounjaro]] both contain tirzepatide. Zepbound is the weight-management brand, while Mounjaro is used for [[type 2 diabetes]]. Patients often search for [[Mounjaro for weight loss]], but treatment choice should be guided by a qualified clinician.

===Can W8MD prescribe Zepbound?===

W8MD physicians can evaluate eligible patients for Zepbound and other [[GLP-1 weight loss injections]] when medically appropriate. Prescribing depends on medical history, eligibility, contraindications, medication access, and insurance or self-pay options.

===Can W8MD help with prior authorization for Zepbound?===

Yes. When insurance coverage is available and the patient qualifies, W8MD physicians can help obtain prior authorization for Zepbound by documenting medical necessity and submitting required clinical information. Approval depends on the insurance plan.

===Does W8MD offer generic tirzepatide?===

W8MD can discuss brand-name Zepbound and tirzepatide-based treatment options depending on patient preference, insurance coverage, availability, safety, and clinical appropriateness. Patients should avoid unverified online tirzepatide or research peptide products.

===How much weight can I lose with Zepbound?===

Weight loss varies. Clinical trials showed greater average weight reduction with Zepbound than placebo when combined with diet and physical activity.<ref name="FDAZepboundWeight" /> Individual results depend on dose, follow-up, nutrition, activity, starting weight, sleep, medical conditions, and long-term adherence.

===Can Zepbound help sleep apnea?===

Yes, Zepbound is FDA-approved for moderate-to-severe [[obstructive sleep apnea]] in adults with obesity.<ref name="FDAZepboundOSA" /> Some patients may still need [[CPAP]], [[APAP]], [[BiPAP]], or other sleep apnea treatment.

===Do I still need diet and exercise?===

Yes. Zepbound is used with a reduced-calorie diet and increased physical activity. W8MD emphasizes protein intake, hydration, meal planning, movement, resistance training, sleep quality, and maintenance.

==Book a Zepbound weight loss appointment==

<div style="background:linear-gradient(135deg,#f5f9ff,#eef7f0); border:1px solid #c9ddf2; border-radius:16px; padding:24px; margin:28px 0; box-shadow:0 3px 10px rgba(0,0,0,0.08);">

[[File:W8MD-Team.jpg|right|220px|link=W8MD Weight Loss, Sleep and MedSpa|alt=W8MD Weight Loss Sleep and MedSpa team]]

<h2 style="margin-top:0; color:#1f4e79;">Request an appointment with W8MD</h2>

<p>W8MD offers physician-supervised [[medical weight loss]], [[Zepbound weight loss]], [[tirzepatide weight loss]], [[GLP-1 weight loss injections]], nutrition support, sleep medicine, and long-term maintenance care in Brooklyn, NY and Philadelphia, PA, with service access for many patients across New York, New Jersey, Connecticut, Pennsylvania, and Delaware.</p>

<div style="display:flex; flex-wrap:wrap; gap:16px; margin:20px 0;">

<div style="flex:1; min-width:280px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:20px;">
<h3 style="margin-top:0; color:#1f4e79;">Brooklyn, NY Office</h3>
<p><strong>Phone:</strong> <span style="font-size:1.25em; color:#0b5cad; font-weight:bold;">718-946-5500</span></p>
<p>For patients searching for [[Zepbound NYC]], [[Zepbound Brooklyn]], [[tirzepatide injections Brooklyn]], [[GLP-1 weight loss shots NYC]], [[Zepbound New Jersey]], or [[Zepbound Connecticut]].</p>
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-45198 Book Brooklyn Appointment]</span>
</div>

<div style="flex:1; min-width:280px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:20px;">
<h3 style="margin-top:0; color:#1f4e79;">Philadelphia, PA Office</h3>
<p><strong>Phone:</strong> <span style="font-size:1.25em; color:#0b5cad; font-weight:bold;">215-676-2334</span></p>
<p>For patients searching for [[Zepbound Philadelphia]], [[Zepbound Pennsylvania]], [[Zepbound Delaware]], [[tirzepatide injections Philadelphia]], or [[GLP-1 shots Philadelphia]].</p>
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-48161 Book Philadelphia Appointment]</span>
</div>

</div>

<div style="background:#fff3cd; border:1px solid #ffe08a; border-radius:10px; padding:14px; margin:18px 0;">
'''Important:''' Please do not submit sensitive medical information, Social Security numbers, insurance ID numbers, or urgent medical concerns through online appointment request forms. If this is a medical emergency, call '''911'''.
</div>

</div>

==Related W8MD and GLP-1 pages==

{{div col|colwidth=18em}}
* [[GLP-1 weight loss injections]]
* [[Zepbound for weight loss]]
* [[Tirzepatide weight loss]]
* [[Tirzepatide injection]]
* [[Tirzepatide side effects]]
* [[Tirzepatide dose escalation]]
* [[Tirzepatide and appetite]]
* [[Tirzepatide and sleep apnea]]
* [[Mounjaro for weight loss]]
* [[Wegovy for weight loss]]
* [[Ozempic for weight loss]]
* [[Semaglutide weight loss]]
* [[Semaglutide injection]]
* [[Semaglutide side effects]]
* [[Semaglutide dose escalation]]
* [[Semaglutide maintenance therapy]]
* [[Food noise]]
* [[Satiety]]
* [[Appetite regulation]]
* [[Gastric emptying]]
* [[Chronic weight management]]
* [[Sleep apnea screening]]
* [[Medical weight loss]]
* [[Obesity medicine]]
{{div col end}}

==Relevant WikiMD links==

* [https://wikimd.org/wiki/Zepbound Zepbound on WikiMD]
* [https://wikimd.org/wiki/Tirzepatide Tirzepatide on WikiMD]
* [https://wikimd.org/wiki/GLP-1_receptor_agonist GLP-1 receptor agonist on WikiMD]
* [https://wikimd.org/wiki/Obesity Obesity on WikiMD]
* [https://wikimd.org/wiki/Weight_loss Weight loss on WikiMD]
* [https://wikimd.org/wiki/Sleep_apnea Sleep apnea on WikiMD]

==External links==

* [https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management FDA - Zepbound approval for chronic weight management]
* [https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea FDA - Zepbound approval for obstructive sleep apnea]
* [https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s002lbl.pdf Zepbound prescribing information]
* [https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss FDA concerns with unapproved GLP-1 drugs used for weight loss]
* [https://zepbound.lilly.com/ Official Zepbound patient website]
* [https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-45198 W8MD Brooklyn appointment request]
* [https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-48161 W8MD Philadelphia appointment request]
{{GLP-1}}
{{Weight loss}}
</div>
[[Category:W8MD]]
[[Category:Weight loss]]
[[Category:GLP-1]]
[[Category:GLP-1 weight loss]]
[[Category:Tirzepatide]]
[[Category:Zepbound]]
[[Category:Medical weight loss]]
[[Category:Anti-obesity medications]]
[[Category:Obesity medicine]]
[[Category:Sleep apnea]]
[[Category:Chronic weight management]]
[[Category:Prescription weight loss medications]]
[[Category:Brooklyn weight loss]]
[[Category:New York City weight loss]]
[[Category:New Jersey weight loss]]
[[Category:Connecticut weight loss]]
[[Category:Philadelphia weight loss]]
[[Category:Pennsylvania weight loss]]
[[Category:Delaware weight loss]]

Zepbound for weight loss - Revision history